CG
NVAX icon

Cutler Group’s Novavax NVAX Stock Holding History

Cutler Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,000
Closed -$2K – 4162
2023
Q2 		$2K Sell
1,000
-1,900
-66% -$14.9K ﹤0.01% 3068
2023
Q1 		$12K Sell
2,900
-27,500
-90% -$253K ﹤0.01% 2217
2022
Q4 		$51K Buy
30,400
+3,400
+13% +$60K ﹤0.01% 1561
2022
Q3 		$1.44M Sell
27,000
-18,800
-41% -$815K 0.1% 210
2022
Q2 		$1.84M Sell
45,800
-48,300
-51% -$2.5M 0.13% 191
2022
Q1 		$2.33M Buy
94,100
+5,800
+7% +$517K 0.12% 182
2021
Q4 		$2.07M Buy
88,300
+67,700
+329% +$11.6M 0.09% 247
2021
Q3 		$389K Buy
20,600
+600
+3% +$132K 0.02% 925
2021
Q2 		$491K Buy
20,000
+16,400
+456% +$3M 0.02% 764
2021
Q1 		$94K Sell
3,600
-13,400
-79% -$2.67M ﹤0.01% 1826
2020
Q4 		$219K Sell
17,000
-5,800
-25% -$616K 0.01% 1033
2020
Q3 		$142K Sell
22,800
-12,400
-35% -$1.51M 0.01% 1106
2020
Q2 		$264K Buy
35,200
+32,600
+1,254% +$1.25M 0.02% 720
2020
Q1 		$2K Buy
+2,600
New +$22K ﹤0.01% 3520
2019
Q2 		– Sell
-1,060
Closed -$10K – 4629
2019
Q1 		$10K Buy
+1,060
New +$33.5K ﹤0.01% 2496
2017
Q1 		– Sell
-320
Closed -$65K – 6946
2016
Q4 		$65K Sell
320
-1,350
-81% -$39.4K ﹤0.01% 2297
2016
Q3 		$70K Buy
1,670
+1,235
+284% +$159K ﹤0.01% 2138
2016
Q2 		$36K Buy
435
+225
+107% +$25.8K ﹤0.01% 2703
2016
Q1 		$30K Sell
210
-220
-51% -$23.6K ﹤0.01% 2844
2015
Q4 		$1K Buy
+430
New +$66.2K ﹤0.01% 6007

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cutler Group's NVAX Position: Q1 2024 in Review

Cutler Group reduced its Novavax (NVAX) stake by 55% in Q1 2024, selling an estimated $2.78K and leaving 500 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Cutler Group first reported a position in NVAX in Q4 2015 and has held it in 28 quarters since. The position peaked at $3.3M in Q4 2021. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Cutler Group held 500 shares of Novavax worth $2K as of Q1 2024.
  • Cutler Group sold 600 Novavax shares in Q1 2024, an estimated $2.78K.
  • Novavax made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1878 holding.
  • Cutler Group first reported a position in Novavax in Q4 2015 and has held it in 28 quarters since.
  • Cutler Group's Novavax position peaked at $3.3M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.